Appointment of Mr. Yogainder Kumar Gupta (DIN:03094998) as Additional Director, Non-executive Independent Director on the Board of Directors of the Company w.e.f. 30th May 2025 for a period of 5 years upto 29th May, 2030, subject to the approval of shareholders in the general meeting.

pdf

Genomic Valley Biotech Ltd.

30 May 2025

48.90

-3.17%

Board Meeting

Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of Board Meeting Pursuant …

BSE India

1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2025. 2. Appointment of Mr. Yogainder Kumar Gupta (DIN: 03094998) as an 'Additional Director' in the category of Non-Executive - Independent Director on the Board of Directors of the Company w.e.f., Friday, 30th May, 2025 to hold office for a term of 5 (five) consecutive years upto May 29, 2030, subject to the approval of the shareholders in the General Meeting. 3. Appointment of M/s. SBR & Co. LLP, Company Secretaries (LLP No. AAO-9057) as the Secretarial Auditors of the Company for Financial year 24-25. 4. Considered Reconstitution of the Committees - Audit Committee, Stakeholders'' Relationship Committee (SRC), Nomination and Remuneration Committee (NRC), Risk Management Committee as per the provisions of the Companies Act, 2013 and the SEBI (LODR) Regulations, 2015.

pdf

Genomic Valley Biotech Ltd.

22 May 2025

48.90

-3.17%

Board Meeting

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Regulation 29 Of SEBI (Listing …

BSE India

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31, 2025.

pdf

Genomic Valley Biotech Ltd.

09 Apr 2025

48.90

-3.17%

Company Update

Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31st March 2025.

pdf

Genomic Valley Biotech Ltd.

17 Feb 2025

48.90

-3.17%

Company Update

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the Newspaper Advertisement Regarding Publications Standalone Un-Audited Financial results of the Company for the Quarter and Nine Months ended 31st December 2024

pdf

Genomic Valley Biotech Ltd.

17 Feb 2025

48.90

-3.17%

Company Update

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the Newspaper Advertisement Regarding Publications Standalone Un-Audited Financial results of the Company for the Quarter and Nine Months ended 31st December 2024

pdf

Genomic Valley Biotech Ltd.

14 Feb 2025

48.90

-3.17%

Corp. Note

Genomic Valley Biotech Ltd - 539206 - Integrated Filing (Financial)

BSE India

Please find enclosed herewith the Integrated Filing (Financial) for the Quarter and Nine Months ended 31st December 2024

pdf

Is Genomic Valley Biotech Ltd. worth buying?

5 Votes:

Buy 40.0%

Sell 40.0%

Hold 20.0%